简体中文 | 繁體中文 | English

Press Releases

2016-02-17 18:05 Momentive Strategically Expands Production Capacity of NXT* Silane in Europe
2016-02-17 17:51 Tommy Hilfiger Takes Next Step to Democratize the Runway with Multi-Media Broadcast Consumer Shows and "Buy Now. Wear Now." Collections
2016-02-17 17:40 CiteAb Names Cell Signaling Technology, “Antibody Company of the Year” and “Researchers’ Choice”
2016-02-17 17:27 World Energy Congress 2016 – Media Registration Open
2016-02-17 16:10 everis and NTT DATA to Develop Digital Archive System for Preserving Treasures from Spain's National Heritage
2016-02-17 15:18 New GSMA Study Calls for Fundamental Review of Digital Ecosystem Regulations
2016-02-17 14:54 Automotive Industry Adopts GSMA Embedded SIM Specification to Accelerate Connected Car Market
2016-02-17 14:39 Xignite Closes $20M Series C Funding Round Led by QUICK Corp.
2016-02-17 11:20 MEDIA ALERT: Visa Unveils Future of Payments and Commerce at Mobile World Congress 2016
2016-02-17 10:55 Ironkey Assets Sold Off - Kanguru Stands As World’s Most Trusted Source for Fully-Integrated USB Hardware / Software Security
2016-02-17 10:34 Rockwell Automation to Acquire MagneMotion, a Leading Manufacturer of Intelligent Conveying Systems
2016-02-17 10:20 CDNetworks Publishes 2015 DDoS Attack Trends and Outlook for 2016
2016-02-17 10:00 Enevate and Sonim Announce a New Strategic Partnership
2016-02-17 09:52 Gigaphoton to Set up Support Bases in Dalian and Xiamen, China
2016-02-17 09:40 SES Welcomes New Vice President, Commercial, for Latin America/North
2016-02-16 18:12 GSMA Announces Security Guidelines to Support Growth of the Internet of Things
2016-02-16 18:05 NTT Communications Ranked Second in HfS Autonomics Premier League Table 2016
2016-02-16 17:55 Ferring announces the start of the PRONOUNCE Trial for patients with advanced prostate cancer and cardiovascular disease receiving degarelix or leuprolide
2016-02-16 16:04 Uganda Deploys Biometric Technology to Improve General Election Transparency
2016-02-16 15:44 ASTRAZENECA’S COMBINATION OF DURVALUMAB WITH TREMELIMUMAB SHOWS CLINICAL ACTIVITY IN NON-SMALL CELL LUNG CANCER IRRESPECTIVE OF PD-L1 STATUS

Business Wire Weibo

Industries

Latest Releases